No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
Express News | Polyrizon Reports Successful Safety Study of a Formulation of Pl-14 Allergy Blocker in Human Nasal Tissue Model
Polyrizon Ltd. Shareholders Approve Key Amendments at Annual Meeting
Express News | Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements
Express News | Polyrizon Ltd - Enters Agreement With Global Branding Consultancy Firm
Polyrizon Engages Leading Branding Firm for Strategic Brand Development